PATENT CLAIM ANALYSIS

Application Number: 16228437
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-05
Patent Classification: ["558", "070000"]

Abstract:
Cell binding agent-drug conjugates comprising phosphinate-based charged linkers and methods of using such linkers and conjugates are provided.

Claim (Index 5):
The compound of  claim 1 , wherein the Drug is selected from the group consisting of tubulysins, maytansinoids, taxanoids, CC-1065 compounds, daunorubicin and doxorubicin compounds, benzodiazepine dimers consisting of dimers of pyrrolobenzodiazepine, tomaymycin, anthramycin, indolinobenzodiazepines, imidazobenzothiadiazepines, and oxazolidinobenzodiazepines, calicheamicins and the enediyne antibiotics, actinomycin, azaserines, bleomycins, epirubicin, tamoxifen, idarubicin, dolastatins/auristatins consisting of monomethyl auristatin E, MMAE, MMAF, auristatin PYE, auristatin TP, auristatins 2-AQ, 6-AQ, EB (AEB), and EFP (AEFP), duocarmycins, thiotepa, vincristine, hemiasterlins, and esperamicins.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 98.0
- Lexical Diversity: 1.1875
- Patent Class: 558.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15118726', '16228130', '16228310', '14432073', '15911571']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8169954652565308
- 35 USC 102 Novelty (BERT): 0.6923058174343674
- Combined Prediction Score: 0.8045265004743145
- Mean Citation Score: 649.908846
- Max Citation Score: 704.9127
- Similarity Product: 646.7514494130493

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test